Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Asset Utilization Ratio (2023 - 2025)

Kura Oncology (KURA) has disclosed Asset Utilization Ratio for 3 consecutive years, with 0.05 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 2179.22% to 0.05 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.05, a 2179.22% increase, with the full-year FY2025 number at 0.09, up 1.05% from a year prior.
  • Asset Utilization Ratio was 0.05 for Q4 2025 at Kura Oncology, up from 0.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q4 2025 to a low of 0.0 in Q4 2023.
  • A 3-year average of 0.01 and a median of 0.0 in 2024 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: grew 22.16% in 2024, then surged 2179.22% in 2025.
  • Kura Oncology's Asset Utilization Ratio stood at 0.0 in 2023, then grew by 22.16% to 0.0 in 2024, then soared by 2179.22% to 0.05 in 2025.
  • Per Business Quant, the three most recent readings for KURA's Asset Utilization Ratio are 0.05 (Q4 2025), 0.03 (Q3 2025), and 0.0 (Q2 2025).